CHENNAI: Isuzu Motors India has raised the warranty package with an ‘extended three years on the Powertrain’ for an additional 50,000 km (whichever occurs earlier). The company had ‘5ecure’ package which offered a ‘five years comprehensive warranty and five years Free Periodic Maintenance’, for 1,50,000 km (whichever occurs earlier). The ‘5ecure’ package on the Isuzu… Continue reading Warranty package on Isuzu mu-X engine extended by three years
Category: News Site
These Adorable 3D-Printed Houses Could Solve Homelessness
Ground Breaking In May, housing nonprofit New Story shared a rendering of plans to 3D-print an entire neighborhood. That vision’s now coming to life, with the Wednesday unveiling of the first houses in this project, in what’ll ultimately become a wholly unique community of 50 homes in Mexico. New Story created the 500-square-foot homes using… Continue reading These Adorable 3D-Printed Houses Could Solve Homelessness
When a Mantis Shrimp Fights a Disco Clam, It Meets Its Match
The mantis shrimp is one of evolution’s greatest hits—literally. This pugnacious crustacean (not technically a shrimp) cocks back its hammer-limbs and smashes prey with such ferocity, a shockwave blows the claws clean off crabs and crumples clamshells like they were papier-mâché. Really, there isn’t much on the tropical seafloor that the mantis shrimp can’t destroy… Continue reading When a Mantis Shrimp Fights a Disco Clam, It Meets Its Match
Tesla Cybertruck will likely get medium-duty truck classification like Ford Super Duty and others
Sponsored Links By Joel Stocksdale While the Ford F-150 has been the claimed target for the Tesla Cybertruck, it looks like the government may classify it like even larger and more capable pickups. As first reported by Automotive News, the electric car company sent a letter to the California Air Resources Board (CARB) suggesting that… Continue reading Tesla Cybertruck will likely get medium-duty truck classification like Ford Super Duty and others
Tesla, GM, & Other EV Companies Seek US Tax Credit Expansion
Invest
Electric Cars
Electric Car Benefits
Electric Car Sales
Solar Energy Rocks
RSS
Advertise
Privacy Policy
Cars
Published on December 13th, 2019 |
by Johnna Crider
Tesla, GM, & Other EV Companies Seek US Tax Credit Expansion
Twitter
LinkedIn
Facebook
December 13th, 2019 by Johnna Crider
MarketWatch reports that Tesla, General Motors, and others in the electric vehicle ecosystem are seeking expansion of the US federal tax credit for EVs.
The tax credit currently starts phasing out when an automaker reaches 200,000 plug-in vehicle sales in the US (something Tesla achieved multiple quarters before any other automaker, and GM achieved second). Tesla buyers will no longer be eligible for any tax credits starting January 1, 2020, under the current system.
The proposal, under the Driving America Forward Act, raises the sales limit to 600,000 instead of 200,000 for each automaker, and the tax credit for buyers changed to $7,000. The Tesla tax credit phaseout under the current system was as follows:
The MarketWatch article shares with us that Tesla, GM, and other electric vehicle manufacturers “have a role in the scramble around a possible tax package with so-called ‘tax extenders,’ as they could score an expansion for a key EV credit. If Tesla and the other EV makers land this credit, it would be a win for anyone purchasing an EV.”
The Driving America Forward Act was introduced by Senator Debbie Stabenow [D-MI]. Some Republicans (known for ties to the oil industry), such as Senator John Barrasso of Wyoming, contend that “it’s time to pull the plug” on EV subsidies (despite over a century of subsidies for oil). He is pushing the Fairness for Every Driver Act instead.
This “fairness” act isn’t really all that fair toward EV drivers since it proposes a user fee on alternative fuel vehicles used in the United States. Why should people have to be punished for being early adopters of EVs and this leaders in cutting pollution and CO2 emissions? If this act was truly fair, it would charge a user fee for gasoline vehicles and perhaps some type of carbon tax that would fund initiatives that help clean up pollution not just in the air but also in rivers, oceans, and other areas that are commonly affected. Or the fund could help those with health problems caused by air pollution.
What do you think? Are you ready to call your senator to push for an EV tax credit expansion?
Follow CleanTechnica on Google News.
It will make you happy & help you live in peace for the rest of your life.
About the Author
Johnna Crider Johnna Crider is a Baton Rouge artist, gem and mineral collector, and Tesla shareholder who believes in Elon Musk and Tesla. Elon Musk advised her in 2018 to “Believe in Good.”
Tesla is one of many good things to believe in. You can find Johnna on Twitter
Back to Top ↑
Advertisement
Advertise with CleanTechnica to get your company in front of millions of monthly readers.
Top News On CleanTechnica
CleanTechnica Clothing & Cups
Join CleanTechnica Today!
Listen to CleanTech TalkAdvertisement
Advertisement
Follow CleanTechnica Follow @cleantechnica
Our Electric Car Driver Report
Read & share our new report on “electric car drivers, what they desire, and what they demand.”
The EV Safety Advantage
Read & share our free report on EV safety, “The EV Safety Advantage.”
EV Charging Guidelines for Cities
Share our free report on EV charging guidelines for cities, “Electric Vehicle Charging Infrastructure: Guidelines For Cities.”
30 Electric Car Benefits
Our Electric Vehicle Reviews
Tesla News
38 Anti-Cleantech Myths
© 2019 Sustainable Enterprises Media, Inc.
Invest
Electric Cars
Electric Car Benefits
Electric Car Sales
Solar Energy Rocks
RSS
Advertise
Privacy Policy
This site uses cookies: Find out more.Okay, thanks
Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
December 13th, 2019 Xconomy New York — A prescription fish-oil pill by Amarin Pharma on Friday received the regulatory nod to expand its use as a supplementary treatment, alongside statins, to more patients at risk of heart attack or stroke. The FDA on Friday approved the drug, icosapent ethyl (Vascepa), for use as a secondary… Continue reading Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
MINI Expects Only 110 Miles Of EPA Range For Cooper SE
110 miles (177 km) is an estimated range figure from MINI. The MINI Cooper SE (aka MINI Electric) will not be the king of range, that is for sure, as the battery is just 32.6 kWh (28.9 kWh available). The official European WLTP rating of 200-232 km (124-144 miles) gave us some guidelines of what… Continue reading MINI Expects Only 110 Miles Of EPA Range For Cooper SE
Tesla Cybertruck Hides Sideview Cameras In Front Fender Flares
The central rearview mirror was replaced with a display. It seems the same is the case with the side mirrors. The recently unveiled Tesla Cybertruck concept prototype (which is expected to be at least slightly modified before entering production) does not have external side mirrors. That does not surprise us much, as some concepts (even… Continue reading Tesla Cybertruck Hides Sideview Cameras In Front Fender Flares
Japan maps and navigation get AI boost with Hitachi, Mapbox partnership
Hitachi Solutions and Mapbox have announced a partnership to sell Mapbox licenses into Japan, a reseller arrangement that will open new opportunities for Japan and globally-based companies to provide AI maps and navigation services into Japan’s enterprise business market. The partnership is effective immediately, and will initially focus on customers in automotive, real estate, logistics,… Continue reading Japan maps and navigation get AI boost with Hitachi, Mapbox partnership
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More
December 13th, 2019 Xconomy National — If you’re keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there’s Sarepta Therapeutics. Late Thursday, the FDA announced approval of the Cambridge, MA, biotech’s drug for Duchenne muscular dystrophy in patients… Continue reading Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More